SCHEMBL20570336

SCHEMBL20570336

Fc1ccc(Nc2nc3nonc3nc2Nc2ccccc2F)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 8/20 0.57
TP53 P04637 5/20 0.57
MAPT P10636 5/20 0.57
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
RAB9A P51151 2/20 0.48
POLB P06746 3/20 0.44
CDKN1A P38936 1/20 0.44
GAA P10253 1/20 0.43
RECQL P46063 1/20 0.43
LMNA P02545 3/20 0.42
HTT P42858 2/20 0.42
TSHR P16473 1/20 0.42
ALDH1A1 P00352 1/20 0.41
AURKA O14965 3/20 0.41
ABCG2 Q9UNQ0 1/20 0.40
EGFR P00533 1/20 0.40
KDR P35968 1/20 0.40
NPC1 O15118 1/20 0.40
LATS1 O95835 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22543309 0.91 SMN1; SMN2 (0.50) SMN1; SMN2TP53MAPTMEN1KMT2A
SCHEMBL31741920 0.91 SMN1; SMN2 (0.50) SMN1; SMN2TP53MAPTMEN1KMT2A
SCHEMBL29774507 0.89 SMN1; SMN2 (0.47) SMN1; SMN2TP53MAPTMEN1KMT2A
SCHEMBL17240563 0.89 SMN1; SMN2 (0.47) SMN1; SMN2TP53MAPTMEN1KMT2A
SCHEMBL22542867 0.89 GAA (0.57) SMN1; SMN2TP53MAPTMEN1KMT2A
SCHEMBL30754768 0.89 GAA (0.57) SMN1; SMN2TP53MAPTMEN1KMT2A
SCHEMBL22542872 0.87 SMN1; SMN2 (0.59) SMN1; SMN2TP53MAPTMEN1KMT2A
SCHEMBL30754719 0.87 SMN1; SMN2 (0.59) SMN1; SMN2TP53MAPTMEN1KMT2A
SCHEMBL3050610 0.86 SMN1; SMN2 (0.67) SMN1; SMN2TP53MAPTMEN1KMT2A
SCHEMBL31741919 0.86 SMN1; SMN2 (0.46) SMN1; SMN2TP53MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3630115-B1 COMPOSITIONS AND METHODS FOR PREPARING AND USING MITOCHONDRIAL UNCOUPLERS UNIV VIRGINIA PATENT FOUNDATION (US) 2025-12-10 EP disclosed
US-11896591-B2 Compositions and methods for preparing and using mitochondrial uncouplers UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2024-02-13 US disclosed
US-20200323846-A1 COMPOSITIONS AND METHODS FOR PREPARING AND USING MITOCHONDRIAL UNCOUPLERS UNIVERSITY OF VIRGINA PATENT FOUNDATION (US) 2020-10-15 US disclosed
US-20200323846-A1 COMPOSITIONS AND METHODS FOR PREPARING AND USING MITOCHONDRIAL UNCOUPLERS UNIVERSITY OF VIRGINA PATENT FOUNDATION (US) 2020-10-15 US disclosed
EP-3630115-A1 COMPOSITIONS AND METHODS FOR PREPARING AND USING MITOCHONDRIAL UNCOUPLERS University Of Virginia Patent Foundation (US) 2020-04-08 EP disclosed
WO-2018217757-A1 COMPOSITIONS AND METHODS FOR PREPARING AND USING MITOCHONDRIAL UNCOUPLERS UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2018-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11896591-B2 Compositions and methods for preparing and using mitochondrial uncouplers ACAD9, GPR119, NDUFAF1 SMN1; SMN2 334/4885TP53 3537/4885MAPT 3834/4885
US-20200323846-A1 COMPOSITIONS AND METHODS FOR PREPARING AND USING MITOCHONDRIAL UNCOUPLERS ACAD9, GPR119, NDUFAF1 SMN1; SMN2 334/4885TP53 3537/4885MAPT 3834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.